23andMe
Search results
Unlock the potential of precision health data to drive scientific breakthroughs. DNAnexus helps 100's hundreds of biomedical organizations accelerate scientific discovery.
Log in to Your Account. Create an Account Forgot your password? Experience the global network for scientific collaboration and accelerated discovery.
DNAnexus® has built the world’s most secure cloud platform and global network for scientific collaboration and accelerated discovery. We embrace challenges and partnership to tackle the world’s most exciting opportunities in human health.
Derive rich insights from precision health data. Easily integrate multiomics and clinical data to perform analyses and generate insights. Leverage bioinformatics tools, JupyterLab notebooks, cohort browsing, and visualization applications all within the DNAnexus platform.
DNAnexus is an American company that provides a cloud-based data analysis and management platform for DNA sequence data. It is based in Mountain View, California, and was founded in 2009 by Stanford University professors Serafim Batzoglou and Arend Sidow and Stanford computer scientist Andreas Sundquist.
Using the DNAnexus Platform. Get to know features you’ll use every day, in a series of short, task-oriented tutorials. Learn to access and use the Platform via both its command-line interface and its user interface. Learn to manage data, users, and work on the Platform, via its API.
Feb 16, 2022 · DNAnexus has built the world’s most secure Big Data cloud platform and global network for scientific collaboration and accelerated discovery.
DNAnexus enables biomedical organizations to accelerate scientific discovery and improve patient care with the Precision Health Data Cloud.
Start unlocking analysis possibilities quickly, with no need to build tools or workflows from scratch or create new code. DNAnexus comes out-of-the-box with everything you need.
Nov 4, 2021 · How DNAnexus Enables Human Longevity to Optimize Genomics Analysis and Interpretation for Healthy Individuals. When the first draft of the human genome was completed in the early 2000s, the possibility of using genomic data in routine healthcare seemed close to becoming reality.
